NCT06348290View on ClinicalTrials.gov

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

September 15, 2024

Conditions
Solid Tumor, Adult
Interventions
DRUG

JMKX001899

Oral

DRUG

Itraconazole

Oral

DRUG

Midazolam

Oral

DRUG

Rifampin

Oral

DRUG

dextromethorphan

Oral

DRUG

Rosuvastatin

Oral

DRUG

digoxin

Oral

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT06348290 - Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | Biotech Hunter | Biotech Hunter